Proposed weight drug price drop only for select few A globally popular weight-loss drug is set for a massive price drop but a top expert is warning most people forking out thousands shouldn't get their hopes up. AAP · Jan 12
Government urged to make nutrition labels on front of food packaging mandatory Which? called on the Government to make the change amid what it described as an ‘obesity crisis’. Evening Standard · Jan 10
Government told to make changes to food packaging in obesity crisis battle People most used the traffic light system when choosing snacks The Independent UK · Jan 10
People regain weight within two years of coming off obesity drugs, new study finds People who use weight-loss drugs can rapidly regain weight after stopping treatment, according to a new study Euronews · Jan 8
Thursday briefing: Why skinny jabs’ short-term fix comes with long-term concerns In today’s newsletter: A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse – leading to questions about long-term impacts and solutions The Guardian - UK · Jan 8
Stopping weight-loss jabs leads to much faster rebound than thought – so are they still worth it? Weight-loss injections, like Wegovy and Mounjaro, have been hailed as gamechangers. In clinical trials, people lost an average of 15%-20% of their body weight – results that seemed almost miraculous compared to traditional diet and exercise programmes. The Conversation · Jan 8
Lack of support leaving people on weight loss drugs vulnerable to nutritional deficiencies, say experts Many taking weight loss drugs could be at risk of ‘replacing one set of health problems with another’, academics warned The Independent UK · Jan 8
People on fat loss jabs ‘put weight back on faster than traditional dieters’ The vast majority of people taking Wegovy and Mounjaro pay privately owing to restrictions on who can access the medicines via the NHS. Evening Standard · Jan 7
How eggs can help you come off Wegovy – cracking the problem of weight-regain For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises… The Conversation · Jan 6
Experts warn ‘loophole’ means junk food advert ban doesn’t go far enough A loophole in the ban means companies can still advertise brand names, which experts argue leaves children no better protected The Independent UK · Jan 6
Tuesday briefing: Will a ban on advertising junk food help to tackle obesity in the UK? In today’s newsletter: As new rules ban TV and online ads for high-fat, salt and sugar products, the curbing of junk food marketing has found cross-party support The Guardian - UK · Jan 6
The Guardian view on the junk food advertising ban: shaping tastes is a job for government Editorial: Weight-loss drugs cannot solve the problem of poor diet. Ministers are right to demand healthier food and promotions The Guardian - UK · Jan 5
Forget BMI – this is the real way to predict how healthy you are, experts say Waist-to-height ratio ‘outperforms’ BMI in identification of serious health risks, analysis of over 120,000 people suggests The Independent UK · Jan 5
Ban on TV junk food advertising before 9pm comes into force in UK Watchdog will also monitor online ban for high fat and sugar products as part of wider effort to tackle childhood obesity The Guardian - UK · Jan 5
The Independent UK · Jan 5 UK ban on adverts for ‘unhealthy’ food comes into effect in bid to tackle obesity The government estimates the advertising ban will prevent around 20,000 cases of childhood obesity
The Independent UK · Jan 4 New crackdown on ads for ‘less healthy food’ to come into full effect The ban applies to products that fall within 13 categories considered to play the most significant role in childhood obesity
Evening Standard · Jan 4 Ban on adverts for ‘less healthy food’ set to come into full effect They will not be allowed to appear on television between 5.30am and 9pm, or online at any time.
The Guardian - UK · Dec 31, 2025 The WHO learned to love ‘anti-obesity’ jabs in 2025. I don’t fully agree, but I get it While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof Devi Sridhar
Barchart · Dec 29, 2025 This Small But Mighty Stock Could Surprise Investors in 2026 This under-the-radar biotech stock is setting up for a big 2026.
Barchart · Dec 25, 2025 As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?
Euronews · Dec 24, 2025 Sleds over screens: Why it’s time to limit your children’s screen time this Christmas Heavy use of phones, tablets and gaming consoles has been linked to anxiety, depression, poor attention and even obesity.
Euronews · Dec 23, 2025 US approves pill version of blockbuster weight-loss drug Wegovy Availability of oral pills to treat obesity could expand the booming market for obesity treatments by broadening access and reducing costs, experts said.
The Independent UK · Dec 23, 2025 FDA approves Wegovy weight-loss pill in first green-lit alternative to injectable GLP-1 drugs U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk
The Guardian - UK · Dec 20, 2025 India’s doctors sound alarm over boom in availability of weight loss jabs Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk
MarketBeat · Dec 16, 2025 Pfizer Adds to Its Big Bet on Weight Loss Drugs A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill.